COMMUNIQUÉ DE PRESSE publié le 30/04/2023 à 12:00, il y a 3 années 1 mois Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
COMMUNIQUÉ DE PRESSE publié le 25/04/2023 à 18:43, il y a 3 années 1 mois EQS-Adhoc: Vita 34 AG publishes outlook for the 2023 financial year
COMMUNIQUÉ DE PRESSE publié le 06/04/2023 à 20:39, il y a 3 années 2 mois EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
Publié le 12/06/2026 à 09:00, il y a 1 heure 58 minutes Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Publié le 12/06/2026 à 09:20, il y a 1 heure 38 minutes CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
Publié le 12/06/2026 à 08:05, il y a 2 heures 53 minutes Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
Publié le 12/06/2026 à 08:00, il y a 2 heures 58 minutes Caledonia Mining Corporation Plc: Utilisation of the Block Admission in Respect of ATM Sales Agreement
Publié le 12/06/2026 à 00:00, il y a 10 heures 58 minutes Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Publié le 12/06/2026 à 10:31, il y a 26 minutes OHB and Helsing joint venture bridges the gap to start-ups – Alliance for Europe’s space sector takes shape
Publié le 12/06/2026 à 10:29, il y a 28 minutes EQS-Adhoc: KHD Humboldt Wedag International AG: KHD wins major contract in the USA
Publié le 12/06/2026 à 10:00, il y a 58 minutes Kora Joins International Air Transport Association's (IATA) Payment Network to Power Airline Payments Across Africa
Publié le 12/06/2026 à 09:35, il y a 1 heure 22 minutes Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
Publié le 12/06/2026 à 09:02, il y a 1 heure 55 minutes CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
